Phytoestrogenic isoflavonoids in epidemiologic and clinical research.

Adrian A Franke, Brunhild M Halm, Kerry Kakazu, Xingnan Li, Laurie J Custer

Journal: Drug testing and analysis 2010;1(1):14-21

PMID: 20355154

Abstract

Isoflavones (IFLs) are natural products to which humans have been traditionally exposed predominantly through soy foods; more recently humans are also exposed to them through soy protein addition to processed foods or through supplements. They are structurally similar to steroidal estrogens and can exert estrogenic or antiestrogenic effects depending on their concentrations and on the tissue considered. These properties qualify IFLs to be classified as phytoestrogens and are believed to account for many of the biological effects observed for soy and/or IFL exposure including benefits for bone and heart health or prevention of menopausal symptoms and certain types of cancer. In order to evaluate the function of IFLs, alone or when exposure happens through soy intake, pharmacokinetics and bioavailability are critical issues to be considered in epidemiologic and clinical research. For this purpose precise, accurate, robust, fast, and affordable techniques for IFL analyses are required.

(c) 2009 John Wiley & Sons, Ltd.

Address: Cancer Research Center of Hawai'i, Natural Products and Cancer Biology Program, Honolulu, HI 96813, USA. [email protected]

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.